Publications
Publications
Show Results For
- All HBS Web
(3,293)
- Faculty Publications (1,403)
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
- October 2009
- Teaching Note
Global Health Partner: Obesity Care
By: Michael E. Porter, Zayed Muhammed Yasin and Jennifer F Baron
Teaching Note for [709494]. View Details
- October 2009 (Revised January 2010)
- Case
The Joslin Diabetes Center
By: Michael E. Porter, Elizabeth Olmsted Teisberg and Scott Wallace
The Joslin Diabetes Center in Boston, Massachusetts is a leading center for diabetes care, clinician training, and research. The incidence of diabetes is rising precipitously worldwide, challenging quality of life with its complications and rapidly accelerating health... View Details
- October 2009 (Revised July 2013)
- Case
Gilead Sciences, Inc.: Access Program
By: V. Kasturi Rangan and Katharine Lee
Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details
- September 2009
- Case
The Risk Management Foundation of the Harvard Medical Institutions, Inc.
By: Richard M.J. Bohmer, Stephen P. Bradley and Natalie Kindred
Through its uniquely proactive approach to medical malpractice risk management, the Risk Management Foundation (RMF) has decreased claims—and premiums—for the Harvard hospitals it insures. The RMF is the captive medico-legal insurer of the Harvard medical institutions... View Details
- September 2009 (Revised April 2010)
- Teaching Note
Brigham and Women's Hospital: Shapiro Cardiovascular Center (TN)
By: Robert S. Huckman and Michael E. Porter
Teaching Note for 608-175. View Details
- September 2009 (Revised May 2011)
- Case
Acumen Fund: Measurement in Impact Investing (A)
By: Alnoor Ebrahim and V. Kasturi Rangan
Acumen Fund is a global venture capital firm with a dual purpose: it looks for a return on its investments, and it also seeks entrepreneurial solutions to global poverty. This case examines Acumen's new projects in Kenya. The organization's investment committee and its... View Details
- September 2009 (Revised August 2012)
- Case
Novasys Medical
By: Richard G. Hamermesh and Lauren Barley
Novasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the... View Details
- 2009
- Working Paper
Operational Failures and Problem Solving: An Empirical Study of Incident Reporting
By: Julia Rose Adler-Milstein, Sara J. Singer and Michael W. Toffel
Operational failures occur in all industries with consequences that range from minor inconveniences to major catastrophes. Many organizations have implemented incident reporting systems to highlight actual and potential operational failures in order to encourage... View Details
- August 2009 (Revised June 2015)
- Case
MINTing Innovation at NewYork-Presbyterian (A)
By: Richard G. Hamermesh and David Kiron
Several top surgeons at NewYork-Presbyterian Hospital (NYP) are receiving financial and administrative support to advance their surgical device inventions through the earliest stages of commercialization. View Details
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
- August 2009
- Case
Intel NBI: Vivonic
By: Willy C. Shih and Thomas Thurston
Vivonic was a start-up that was part of Intel's New Business Initiatives that sought to develop and sell personal health monitoring hardware and software. When it was first funded, Intel was in the midst of record growth and was seeking diversification. But the company... View Details
- 2009
- Working Paper
Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery
By: David M. Cutler, Robert S. Huckman and Jonathan T. Kolstad
Prior studies suggest that, with elastically supplied inputs, free entry may lead to an inefficiently high number of firms in equilibrium. Under input scarcity, however, the welfare loss from free entry is reduced. Further, free entry may increase use of high-quality... View Details
- 2009
- Working Paper
Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery
By: David M. Cutler, Robert S. Huckman and Jonathan T. Kolstad
Prior studies suggest that, with elastically supplied inputs, free entry may lead to an inefficiently high number of firms in equilibrium. Under input scarcity, however, the welfare loss from free entry is reduced. Further, free entry may increase use of high-quality... View Details
- July 2009 (Revised May 2010)
- Case
Pfizer: Letter from the Chairman (A)
By: Robert L. Simons and Natalie Kindred
This case explores maximizing shareholder value as a goal in executive decision making. Over a period of nine years, three different Pfizer CEOs make critical decisions intended to increase shareholder value. But the results are disappointing. To allow students to... View Details
- June 2009 (Revised April 2011)
- Case
Cincinnati Children's Hospital Medical Center
By: Anita L. Tucker and Amy C. Edmondson
The case describes an organization's use of the science of improvement to transform their process quality from below average to the top 10% in their industry. The case outlines the protagonist's strategy of developing internal experts who are trained in a common... View Details
- May 2009 (Revised August 2010)
- Case
The Jenner Situation
By: Richard G. Hamermesh, Andy Whittemore and Eliot Sherman
Dr. Bill Lemont is the new chief medical officer of a large academic medical center. During his first week on the job he has become aware of the abusive behavior and temper outbursts of a prominent orthopedic surgeon. How Dr. Lemont handles the situation will be... View Details
- May 2009
- Case
Global Health Partner: Obesity Care
By: Michael E. Porter, Zayed Muhammed Yasin and Jennifer F Baron
Global Health Partner (GHP) was founded in 2006 as a privately owned health care provider in Sweden serving both public and private paying patients. In contrast to most providers in the country, GHP organized around specific service lines where it saw the potential to... View Details
- April 2009 (Revised April 2010)
- Supplement
Merck: Managing Vioxx (B)
By: Robert L. Simons, Kathryn Rosenberg and Natalie Kindred